A股異動 | 大飛機板塊普漲 美國批准向中國出口用於C919的發動機
格隆匯4月9日丨大飛機板塊普漲,新餘國科、南方軸承漲停,愛樂達漲逾5%,航天晨光、中航飛機、安達維爾漲逾1%,德威新材、航天科技跟漲。通用電氣公司發言人當地時間4月7日表示,已經從特朗普政府獲得出口許可,允許其向中國商飛C919客機出口航空發動機。而在今年2月中旬,美國政府曾經宣佈考慮阻止通用電氣向中國該款發動機。業內人士認為,如今美國解除對中國的發動機出口,不但挽救了通用的業績壓力和大量員工就業問題,同時也讓國內的大飛機生產交付再度激活,產業鏈鏈條供應商有望迎來明顯利好。建議關注大飛機產業鏈,尤其是核心發動機之外的零配件供應商。格隆匯平台近日發佈研究文章《美國批准向中國出口用於C919的發動機,關注大飛機產業鏈》,可點擊鏈接參閲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.